Article List

WPRIM Management System> DCMS> Clinical Psychopharmacology and Neuroscience> 2016> 14> 2

Volume: 14 Issue: 2

1. Risperidone-induced Gingival Bleeding in a Pediatric Case: A Dose-dependent Side Effect.	Page:210—211
2. Heritability and Familiality of Temperament and Character Dimensions in Korean Families with Schizophrenic Linkage Disequilibrium.	Page:203—209
3. Expected Emotional Usefulness and Emotional Preference in Individuals with Major Depressive Disorder.	Page:194—202
4. The Effect of Single Dose Methylphenidate on Neurometabolites according to COMT Gene Val158Met Polymorphism in the Patient with Attention Deficit Hyperactivity Disorder: A Study Using Magnetic Resonance Spectroscopy.	Page:184—193
5. The Efficacy and Safety of Clonazepam in Patients with Anxiety Disorder Taking Newer Antidepressants: A Multicenter Naturalistic Study.	Page:177—183
6. Heart Rate Variability and the Efficacy of Biofeedback in Heroin Users with Depressive Symptoms.	Page:168—176
7. Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study.	Page:161—167
8. Adjunctive Low-frequency Repetitive Transcranial Magnetic Stimulation over the Right Dorsolateral Prefrontal Cortex in Patients with Treatment-resistant Obsessive-compulsive Disorder: A Randomized Controlled Trial.	Page:153—160
9. The Ratio of 2nd to 4th Digit Length in Korean Alcohol-dependent Patients.	Page:148—152
10. The Microbiome and Mental Health: Looking Back, Moving Forward with Lessons from Allergic Diseases.	Page:131—147
11. Staging Models in Bipolar Disorder: A Systematic Review of the Literature.	Page:117—130
12. Neuroscience-based Nomenclature (NbN) for Clinical Psychopharmacology and Neuroscience.	Page:115—116
13. An Unusual, Paradoxical Arousal with Alprazolam in a Dependant User.	Page:229—230
14. Use of Clozapine for Borderline Personality Disorder: A Case Report.	Page:226—228
15. Acute Dystonia Following a Switch in Treatment from Atomoxetine to Low-dose Aripiprazole.	Page:221—225
16. Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus.	Page:218—220
17. Late Onset Agranulocytosis with Clozapine Associated with HLA DR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature.	Page:212—217